These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36731621)

  • 21. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Chemokines in the Pathogenesis of Visceral Leishmaniasis.
    Kumar R; Bhatia M; Pai K
    Curr Med Chem; 2022; 29(33):5441-5461. PubMed ID: 35579167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.
    Kumar P; Misra P; Thakur CP; Saurabh A; Rishi N; Mitra DK
    Clin Exp Immunol; 2018 Mar; 191(3):318-327. PubMed ID: 29058314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
    Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
    Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.
    Sher A; Gazzinelli RT; Oswald IP; Clerici M; Kullberg M; Pearce EJ; Berzofsky JA; Mosmann TR; James SL; Morse HC
    Immunol Rev; 1992 Jun; 127():183-204. PubMed ID: 1354651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.
    Banerjee A; Bhattacharya P; Joshi AB; Ismail N; Dey R; Nakhasi HL
    Cell Immunol; 2016 Nov; 309():37-41. PubMed ID: 27444130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
    Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
    Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
    Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
    Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine profile and pathology in human leishmaniasis.
    Ribeiro-de-Jesus A; Almeida RP; Lessa H; Bacellar O; Carvalho EM
    Braz J Med Biol Res; 1998 Jan; 31(1):143-8. PubMed ID: 9686192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.
    Chamakh-Ayari R; Bras-Gonçalves R; Bahi-Jaber N; Petitdidier E; Markikou-Ouni W; Aoun K; Moreno J; Carrillo E; Salotra P; Kaushal H; Negi NS; Arevalo J; Falconi-Agapito F; Privat A; Cruz M; Pagniez J; Papierok GM; Rhouma FB; Torres P; Lemesre JL; Chenik M; Meddeb-Garnaoui A
    PLoS One; 2014; 9(5):e92708. PubMed ID: 24786587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis?
    Soares RR; Antinarelli LMR; Abramo C; Macedo GC; Coimbra ES; Scopel KKG
    Pathog Glob Health; 2017 May; 111(3):107-115. PubMed ID: 28353409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.
    Avishek K; Kaushal H; Gannavaram S; Dey R; Selvapandiyan A; Ramesh V; Negi NS; Dubey US; Nakhasi HL; Salotra P
    Sci Rep; 2016 Sep; 6():33059. PubMed ID: 27624408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathology of leishmaniasis: an update.
    Mansueto P; Vitale G; Di Lorenzo G; Rini GB; Mansueto S; Cillari E
    Int J Immunopathol Pharmacol; 2007; 20(3):435-45. PubMed ID: 17880757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+FOXP3+ cells produce IL-10 in the spleens of dogs with visceral leishmaniasis.
    Silva KL; de Andrade MM; Melo LM; Perosso J; Vasconcelos RO; Munari DP; Lima VM
    Vet Parasitol; 2014 May; 202(3-4):313-8. PubMed ID: 24703254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of regulatory T cells during experimental Leishmania infantum infection.
    Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM
    Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.